136 related articles for article (PubMed ID: 36001256)
21. Chronic non-cancer pain among adults with substance use disorders: Prevalence, characteristics, and association with opioid overdose and healthcare utilization.
John WS; Wu LT
Drug Alcohol Depend; 2020 Apr; 209():107902. PubMed ID: 32088587
[TBL] [Abstract][Full Text] [Related]
22. Stigma as a fundamental hindrance to the United States opioid overdose crisis response.
Tsai AC; Kiang MV; Barnett ML; Beletsky L; Keyes KM; McGinty EE; Smith LR; Strathdee SA; Wakeman SE; Venkataramani AS
PLoS Med; 2019 Nov; 16(11):e1002969. PubMed ID: 31770387
[TBL] [Abstract][Full Text] [Related]
23. Preoperative Opioid Misuse is Associated With Increased Morbidity and Mortality After Elective Orthopaedic Surgery.
Menendez ME; Ring D; Bateman BT
Clin Orthop Relat Res; 2015 Jul; 473(7):2402-12. PubMed ID: 25694266
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology of emergency department visits for opioid overdose: a population-based study.
Hasegawa K; Brown DF; Tsugawa Y; Camargo CA
Mayo Clin Proc; 2014 Apr; 89(4):462-71. PubMed ID: 24629443
[TBL] [Abstract][Full Text] [Related]
25. Trends in prescription opioid use and dose trajectories before opioid use disorder or overdose in US adults from 2006 to 2016: A cross-sectional study.
Wei YJ; Chen C; Fillingim R; Schmidt SO; Winterstein AG
PLoS Med; 2019 Nov; 16(11):e1002941. PubMed ID: 31689302
[TBL] [Abstract][Full Text] [Related]
26. Prevention and Treatment of Opioid Overdose and Opioid-Use Disorders.
Phillips KA; Preston KL
Addict Behav; 2018 Nov; 86():1-3. PubMed ID: 30080480
[No Abstract] [Full Text] [Related]
27. Opioid Overdose Hospitalizations among Medicare-Disability Beneficiaries.
Peters JL; Durand WM; Monteiro KA; Dumenco L; George P
J Am Board Fam Med; 2018; 31(6):881-896. PubMed ID: 30413544
[TBL] [Abstract][Full Text] [Related]
28. Types of Opioid Harms in Canadian Hospitals: Comparing Canada and Australia.
Frood J; Paltser G
Healthc Q; 2019 Jul; 22(2):10-12. PubMed ID: 31556372
[TBL] [Abstract][Full Text] [Related]
29. Characteristics and outcomes of hospitalizations and readmissions for opioid dependence and overdose: nationally representative data.
Grzebinski S; Stein L; Dhamoon MS
Subst Abus; 2021; 42(4):654-661. PubMed ID: 33044910
[No Abstract] [Full Text] [Related]
30. Association of Gabapentinoids With the Risk of Opioid-Related Adverse Events in Surgical Patients in the United States.
Bykov K; Bateman BT; Franklin JM; Vine SM; Patorno E
JAMA Netw Open; 2020 Dec; 3(12):e2031647. PubMed ID: 33372975
[TBL] [Abstract][Full Text] [Related]
31. An Examination of Claims-based Predictors of Overdose from a Large Medicaid Program.
Cochran G; Gordon AJ; Lo-Ciganic WH; Gellad WF; Frazier W; Lobo C; Chang CH; Zheng P; Donohue JM
Med Care; 2017 Mar; 55(3):291-298. PubMed ID: 27984346
[TBL] [Abstract][Full Text] [Related]
32. Association of Opioid-Related Adverse Drug Events With Clinical and Cost Outcomes Among Surgical Patients in a Large Integrated Health Care Delivery System.
Shafi S; Collinsworth AW; Copeland LA; Ogola GO; Qiu T; Kouznetsova M; Liao IC; Mears N; Pham AT; Wan GJ; Masica AL
JAMA Surg; 2018 Aug; 153(8):757-763. PubMed ID: 29799927
[TBL] [Abstract][Full Text] [Related]
33. Adverse events among adult Medicaid enrollees with opioid use disorder and co-occurring substance use disorders.
O'Brien P; Henke RM; Schaefer MB; Lin J; Creedon TB
Drug Alcohol Depend; 2021 Apr; 221():108555. PubMed ID: 33596496
[TBL] [Abstract][Full Text] [Related]
34. Opioid overdose leading to intensive care unit admission: Epidemiology and outcomes.
Pfister GJ; Burkes RM; Guinn B; Steele J; Kelley RR; Wiemken TL; Saad M; Ramirez J; Cavallazzi R
J Crit Care; 2016 Oct; 35():29-32. PubMed ID: 27481733
[TBL] [Abstract][Full Text] [Related]
35. The impact of COVID-19 on healthcare delivery for people who use opioids: a scoping review.
Alexander K; Pogorzelska-Maziarz M; Gerolamo A; Hassen N; Kelly EL; Rising KL
Subst Abuse Treat Prev Policy; 2021 Aug; 16(1):60. PubMed ID: 34372900
[TBL] [Abstract][Full Text] [Related]
36. Presence of opioid safety initiatives, prescribing patterns for opioid and naloxone, and perceived barriers to prescribing naloxone: Cross-sectional survey results based on practice type, scope, and location.
Kohan LR; Elmofty D; Pena I; Liao C
J Opioid Manag; 2021; 17(1):19-38. PubMed ID: 33735425
[TBL] [Abstract][Full Text] [Related]
37. Frequency of Cardiovascular Events and In-hospital Mortality With Opioid Overdose Hospitalizations.
Doshi R; Majmundar M; Kansara T; Desai R; Shah J; Kumar A; Patel K
Am J Cardiol; 2019 Nov; 124(10):1528-1533. PubMed ID: 31521260
[TBL] [Abstract][Full Text] [Related]
38. Opioid analgesic dose and the risk of misuse, overdose, and death: A narrative review.
Coyle DT; Pratt CY; Ocran-Appiah J; Secora A; Kornegay C; Staffa J
Pharmacoepidemiol Drug Saf; 2018 May; 27(5):464-472. PubMed ID: 29243305
[TBL] [Abstract][Full Text] [Related]
39. Risk Factors for Opioid-Use Disorder and Overdose.
Webster LR
Anesth Analg; 2017 Nov; 125(5):1741-1748. PubMed ID: 29049118
[TBL] [Abstract][Full Text] [Related]
40. The opioid epidemic in pediatrics: a 2020 update.
Yaster M; McNaull PP; Davis PJ
Curr Opin Anaesthesiol; 2020 Jun; 33(3):327-334. PubMed ID: 32371640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
